Vinge has, together with Norton Rose Fulbright, advised Anglo American Limited in the deal. Anglo American Limited entered into a royalty agreement of USD 10 million and a...
You must be a Standard 1 Year member to access this content.
Vinge has advised Svea Bank AB on the deal. Svea Bank AB announced its issuance of additional tier 1 capital (AT1) of SEK 300 million to optimise...
You must be a Standard 1 Year member to access this content.
Vinge advised Dreams AB on the deal. Dreams AB announced the divestment of the leading engagement banking platform Dreams Technology to Doconomy which expands suite of...
You must be a Standard 1 Year member to access this content.
Vinge advised Biotage AB on the deal. Global investment firm KKR’s life science platform Gamma Biosciences has sold Astrea Bioseparations, a company focused on helping to bring small...
You must be a Standard 1 Year member to access this content.
Vinge has advised Danske Bank A/S, Danmark, Sverige Filial on the deal. Danske Bank A/S, Danmark, Sverige Filial signed a new SEK 750 million credit facility for...
You must be a Standard 1 Year member to access this content.
Vinge advised Immunovia on the deal. Immunovia AB (publ) has resolved on a new issue of shares of approximately SEK 202.2 million with preferential right for...
You must be a Standard 1 Year member to access this content.
Vinge advised CapMan Buyout on the deal. Funds managed by CapMan Buyout and other shareholders of the Malte Månson group signed an agreement to divest the...
You must be a Standard 1 Year member to access this content.
Vinge has advised Scandic Hotels Group on the deal. Scandic Hotels Group AB entered into of a SEK 3,450,000,000 facilities agreement. The facilities agreement matures on...
You must be a Standard 1 Year member to access this content.
Vinge advised AmSpec on the deal. Morris Law advised the sellers. AmSpec Group, Inc., together with its subsidiaries (“AmSpec”), is a multinational group of companies within...
You must be a Standard 1 Year member to access this content.
Vinge has advised Veeco Instruments Inc. on the deal. Synch has acted as legal advisor to the shareholders of Epiluvac AB. Veeco Instruments Inc., a US...
You must be a Standard 1 Year member to access this content.
Vinge has advised Egetis Therapeutics AB on the deal. Egetis Therapeutics AB (publ), an innovative and integrated pharmaceutical company focusing on projects in late-stage development for commercialization...
You must be a Standard 1 Year member to access this content.
Vinge has advised Samhällsbyggnadsbolaget i Norden AB (SBB) on the deal. Samhällsbyggnadsbolaget i Norden AB (“SBB”) in announced the distribution of the shares in Neobo Fastigheter...
You must be a Standard 1 Year member to access this content.
